Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
69
EME Quote, Financials, Valuation and Earnings
Last price:
$482.81
Seasonality move
:
0.74%
Day range:
$468.83 - $486.57
52-week range:
$319.49 - $545.30
Dividend yield:
0.21%
P/E ratio:
21.38x
P/S ratio:
1.50x
P/B ratio:
7.34x
Volume:
435.3K
Avg. volume:
482.6K
1-year change:
29.67%
Market cap:
$21.7B
Revenue:
$14.6B
EPS (TTM):
$22.63
EMCOR Group Number of Institutional Trades
EMCOR Group Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$13.9B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$26.8B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EMCOR Group Institutional Ownership
-
What Percentage Of EME Is Owned by Institutions?
-- of EME is owned by institutions.
-
How Many Institutions Own EME Shares?
EMCOR Group stock is owned by 1,658 institutional shareholders at this time.
-
Have Institutions Been Buying EME Stock?
Yes, institutions have bought 18.9M shares of EME in the last quarter.
-
Have Institutions Been Selling EME Stock?
Yes, institutions have sold 33M shares of EME over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
